Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Herpes Simplex Virus-Type1 (HSV-1) Impairs DNA Repair in Cortical Neurons.

De Chiara G, Racaniello M, Mollinari C, Marcocci ME, Aversa G, Cardinale A, Giovanetti A, Garaci E, Palamara AT, Merlo D.

Front Aging Neurosci. 2016 Oct 18;8:242.

PMID:
27803664
2.

Putting translational science on to a global stage.

Gilliland CT, Zuk D, Kocis P, Johnson M, Hay S, Hajduch M, Bietrix F, Aversa G, Austin CP, Ussi AE.

Nat Rev Drug Discov. 2016 Apr;15(4):217-8. doi: 10.1038/nrd.2016.33.

PMID:
27032820
3.

Role of human topoisomerase IB on ionizing radiation induced damage.

Jahan Z, Castelli S, Aversa G, Rufini S, Desideri A, Giovanetti A.

Biochem Biophys Res Commun. 2013 Mar 15;432(3):545-8. doi: 10.1016/j.bbrc.2013.02.032.

PMID:
23422507
4.

Intraocular pressure elevations with loteprednol etabonate: a retrospective chart review.

Rajpal RK, Digby D, D'Aversa G, Mah F, Hollander DA, Conway T.

J Ocul Pharmacol Ther. 2011 Jun;27(3):305-8. doi: 10.1089/jop.2010.0182.

PMID:
21574815
5.

The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy.

Su MY, Perry HD, Barsam A, Perry AR, Donnenfeld ED, Wittpenn JR, D'Aversa G.

Cornea. 2011 Oct;30(10):1098-104. doi: 10.1097/ICO.0b013e318206caee.

PMID:
21407074
6.

Correlating patient-reported response to hydroxypropyl cellulose ophthalmic insert (LACRISERT®) therapy with clinical outcomes: tools for predicting response.

McDonald M, D'Aversa G, Perry HD, Wittpenn JR, Nelinson DS.

Curr Eye Res. 2010 Oct;35(10):880-7. doi: 10.3109/02713683.2010.495811.

PMID:
20858108
7.

Hydroxypropyl cellulose ophthalmic inserts (lacrisert) reduce the signs and symptoms of dry eye syndrome and improve patient quality of life.

McDonald M, D'Aversa G, Perry HD, Wittpenn JR, Donnenfeld ED, Nelinson DS.

Trans Am Ophthalmol Soc. 2009 Dec;107:214-21.

PMID:
20126497
8.

The mythic function of narcissism.

Aversa GL, Baldieri V, Marozza MI.

J Anal Psychol. 2004 Sep;49(4):553-68.

PMID:
15317532
9.

A novel role for p21-activated protein kinase 2 in T cell activation.

Chu PC, Wu J, Liao XC, Pardo J, Zhao H, Li C, Mendenhall MK, Pali E, Shen M, Yu S, Taylor VC, Aversa G, Molineaux S, Payan DG, Masuda ES.

J Immunol. 2004 Jun 15;172(12):7324-34.

PMID:
15187108
10.

Interleukin 10 regulates cell surface and soluble LIR-2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro.

Beinhauer BG, McBride JM, Graf P, Pursch E, Bongers M, Rogy M, Korthauer U, de Vries JE, Aversa G, Jung T.

Eur J Immunol. 2004 Jan;34(1):74-80.

PMID:
14971032
11.

Systematic identification of regulatory proteins critical for T-cell activation.

Chu P, Pardo J, Zhao H, Li CC, Pali E, Shen MM, Qu K, Yu SX, Huang BC, Yu P, Masuda ES, Molineaux SM, Kolbinger F, Aversa G, de Vries J, Payan DG, Liao XC.

J Biol. 2003;2(3):21.

PMID:
12974981
12.

IL-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses.

McBride JM, Jung T, de Vries JE, Aversa G.

Cell Immunol. 2002 Feb;215(2):162-72.

PMID:
12202153
13.

Signaling lymphocytic activation molecule expression and regulation in human intracellular infection correlate with Th1 cytokine patterns.

GarcĂ­a VE, Quiroga MF, Ochoa MT, Ochoa L, Pasquinelli V, Fainboim L, Olivares LM, Valdez R, Sordelli DO, Aversa G, Modlin RL, Sieling PA.

J Immunol. 2001 Nov 15;167(10):5719-24.

PMID:
11698444
14.

Functional cloning of Src-like adapter protein-2 (SLAP-2), a novel inhibitor of antigen receptor signaling.

Holland SJ, Liao XC, Mendenhall MK, Zhou X, Pardo J, Chu P, Spencer C, Fu A, Sheng N, Yu P, Pali E, Nagin A, Shen M, Yu S, Chan E, Wu X, Li C, Woisetschlager M, Aversa G, Kolbinger F, Bennett MK, Molineaux S, Luo Y, Payan DG, Mancebo HS, Wu J.

J Exp Med. 2001 Nov 5;194(9):1263-76.

PMID:
11696592
15.

Signaling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicity.

Henning G, Kraft MS, Derfuss T, Pirzer R, de Saint-Basile G, Aversa G, Fleckenstein B, Meinl E.

Eur J Immunol. 2001 Sep;31(9):2741-50.

PMID:
11536173
16.

Transmembrane-sequence-dependent overexpression and secretion of glycoproteins in Saccharomyces cerevisiae.

Schuster M, Wasserbauer E, Aversa G, Jungbauer A.

Protein Expr Purif. 2001 Feb;21(1):1-7.

PMID:
11162380
17.

Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells.

Castro AG, Hauser TM, Cocks BG, Abrams J, Zurawski S, Churakova T, Zonin F, Robinson D, Tangye SG, Aversa G, Nichols KE, de Vries JE, Lanier LL, O'Garra A.

J Immunol. 1999 Dec 1;163(11):5860-70.

PMID:
10570270
18.

Altered signaling lymphocytic activation molecule (SLAM) expression in HIV infection and redirection of HIV-specific responses via SLAM triggering.

Meroni L, Fusi ML, Varchetta S, Biasin M, Rusconi S, Villa ML, De Vries JE, Aversa G, Galli M, Clerici M.

Clin Immunol. 1999 Sep;92(3):276-84.

PMID:
10479532
19.

Receptors and cytokines involved in allergic TH2 cell responses.

de Vries JE, Carballido JM, Aversa G.

J Allergy Clin Immunol. 1999 May;103(5 Pt 2):S492-6. Review.

PMID:
10329853
20.

IFN-gamma is only partially restored by co-stimulation with IL-12, IL-2, IL-15, IL-18 or engagement of CD28.

Jung T, Witzak K, Dieckhoff K, Zachmann K, Heidrich S, Aversa G, Neumann C.

Clin Exp Allergy. 1999 Feb;29(2):207-16.

PMID:
10051725
Items per page

Supplemental Content

Loading ...
Support Center